Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong
· Delayed Price · Currency is HKD 5.32
-0.08 (-1.48%)
Apr 29, 2026, 4:08 PM HKT
Lepu Biopharma Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Net Income | - | -411.38 | -22.1 | -689.05 | -1,011 | Upgrade
|
| Depreciation & Amortization | - | 100.03 | 102.43 | 95.45 | 95.25 | Upgrade
|
| Other Amortization | - | 0.15 | 0.15 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.01 | - | -0.61 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | -220.26 | - | -5.37 | Upgrade
|
| Loss (Gain) on Equity Investments | - | 16.44 | 27.34 | 32.23 | 17.7 | Upgrade
|
| Stock-Based Compensation | - | 4.4 | 18.57 | 30.42 | 113.51 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 0.2 | 0.21 | - | - | Upgrade
|
| Other Operating Activities | - | 5.73 | -168.87 | 21.97 | 58.61 | Upgrade
|
| Change in Accounts Receivable | - | -8.22 | -38.01 | - | -20.37 | Upgrade
|
| Change in Inventory | - | 6.63 | -5.35 | 0.12 | -4.62 | Upgrade
|
| Change in Accounts Payable | - | 28.52 | 41.48 | 2.55 | 134.56 | Upgrade
|
| Change in Unearned Revenue | - | 7.11 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | - | 53.99 | 13.58 | 25.99 | - | Upgrade
|
| Operating Cash Flow | - | -196.39 | -250.84 | -480.93 | -621.74 | Upgrade
|
| Capital Expenditures | - | -32.92 | -28 | -110.45 | -213.39 | Upgrade
|
| Cash Acquisitions | - | - | - | -10 | -100 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -28.83 | -13.2 | -5 | -6.12 | Upgrade
|
| Investment in Securities | - | - | 125.14 | 50.79 | 315.61 | Upgrade
|
| Investing Cash Flow | - | -61.75 | 83.94 | -74.66 | -3.89 | Upgrade
|
| Long-Term Debt Issued | - | 584.41 | 403.55 | 437.46 | 146.11 | Upgrade
|
| Total Debt Issued | - | 584.41 | 403.55 | 437.46 | 146.11 | Upgrade
|
| Long-Term Debt Repaid | - | -488.63 | -383.99 | -88.76 | -15.82 | Upgrade
|
| Total Debt Repaid | - | -488.63 | -383.99 | -88.76 | -15.82 | Upgrade
|
| Net Debt Issued (Repaid) | - | 95.78 | 19.56 | 348.7 | 130.3 | Upgrade
|
| Issuance of Common Stock | - | 213.38 | - | 739.23 | 261.12 | Upgrade
|
| Other Financing Activities | - | -77.07 | -96.26 | -55.96 | -11.11 | Upgrade
|
| Financing Cash Flow | - | 232.08 | -76.7 | 1,032 | 380.31 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 1.33 | 0.21 | 37.86 | -2.38 | Upgrade
|
| Net Cash Flow | - | -24.73 | -243.38 | 514.23 | -247.7 | Upgrade
|
| Free Cash Flow | - | -229.31 | -278.84 | -591.38 | -835.12 | Upgrade
|
| Free Cash Flow Margin | - | -62.35% | -123.73% | -3797.71% | - | Upgrade
|
| Free Cash Flow Per Share | - | -0.14 | -0.17 | -0.36 | -0.55 | Upgrade
|
| Cash Interest Paid | - | 28.25 | 29.38 | 21.39 | 9.29 | Upgrade
|
| Levered Free Cash Flow | - | -185.08 | -227.17 | -449.59 | -514.38 | Upgrade
|
| Unlevered Free Cash Flow | - | -171.55 | -217.99 | -444.93 | -512.69 | Upgrade
|
| Change in Working Capital | - | 88.03 | 11.7 | 28.67 | 109.58 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.